Načítá se...
HDL flux is higher in patients with nonalcoholic fatty liver disease
Altered lipid metabolism and inflammation are involved in the pathogenesis of both nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease (CVD). Even though high-density lipoprotein (HDL), a CVD protective marker, is decreased, whether HDL metabolism and function are perturbed in NAFLD...
Uloženo v:
| Vydáno v: | Am J Physiol Endocrinol Metab |
|---|---|
| Hlavní autoři: | , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Physiological Society
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6879863/ https://ncbi.nlm.nih.gov/pubmed/31503515 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpendo.00193.2019 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|